- Home
- WSFS vs IOVA Comparison
WSFS vs IOVA Comparison
Compare WSFS & IOVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WSFS
- IOVA
- Stock Information
- Founded
- WSFS 1980
- IOVA 2007
- Country
- WSFS United States
- IOVA United States
- Employees
- WSFS N/A
- IOVA N/A
- Industry
- WSFS Major Banks
- IOVA Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- WSFS Finance
- IOVA Health Care
- Exchange
- WSFS Nasdaq
- IOVA Nasdaq
- Market Cap
- WSFS 3.1B
- IOVA 2.6B
- IPO Year
- WSFS N/A
- IOVA N/A
- Fundamental
- Price
- WSFS $54.12
- IOVA $5.91
- Analyst Decision
- WSFS Buy
- IOVA Strong Buy
- Analyst Count
- WSFS 4
- IOVA 9
- Target Price
- WSFS $59.00
- IOVA $23.33
- AVG Volume (30 Days)
- WSFS 321.2K
- IOVA 9.0M
- Earning Date
- WSFS 01-27-2025
- IOVA 02-26-2025
- Dividend Yield
- WSFS 1.12%
- IOVA N/A
- EPS Growth
- WSFS N/A
- IOVA N/A
- EPS
- WSFS 4.39
- IOVA N/A
- Revenue
- WSFS $971,986,000.00
- IOVA $90,858,000.00
- Revenue This Year
- WSFS N/A
- IOVA $13,758.71
- Revenue Next Year
- WSFS N/A
- IOVA $171.20
- P/E Ratio
- WSFS $12.18
- IOVA N/A
- Revenue Growth
- WSFS 4.32
- IOVA 12751.20
- 52 Week Low
- WSFS $40.20
- IOVA $5.62
- 52 Week High
- WSFS $62.75
- IOVA $18.33
- Technical
- Relative Strength Index (RSI)
- WSFS 50.18
- IOVA 28.87
- Support Level
- WSFS $52.98
- IOVA $5.62
- Resistance Level
- WSFS $55.36
- IOVA $6.44
- Average True Range (ATR)
- WSFS 1.48
- IOVA 0.45
- MACD
- WSFS 0.24
- IOVA -0.10
- Stochastic Oscillator
- WSFS 77.37
- IOVA 11.46
About WSFS WSFS Financial Corporation
WSFS Financial Corp is a savings and loan holding company. The company operates in three segments: WSFS Bank provides loans and leases and other financial products to commercial and consumer customers. Cash Connect segment provides ATM vault cash, smart safe, and other cash logistics services; and Wealth Management provides a broad array of planning and advisor services, investment management, personal and institutional trust services, and credit and deposit products to individuals, corporate, and institutional clients. Majority revenue is generated from WSFS Bank segment.
About IOVA Iovance Biotherapeutics Inc.
Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. its objective is to be the leader in innovating, developing, and delivering tumor-infiltrating lymphocyte, or TIL, therapies for patients with solid tumor cancers.